Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 26 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer…

Grant US-11598776-B2

United States of America

Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for…

Grant US-11547705-B2

United States of America

Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor

Grant US-11369623-B2

United States of America

High-purity quinoline derivative and method for manufacturing same

Grant US-11186547-B2

United States of America

Method for suppressing bitterness of quinoline derivative

Grant US-11090386-B2

United States of America